TruAlt Bioenergy Limited
All news and filings related to TruAlt Bioenergy Limited.
View all news & filings- Low impact
TruAlt Bioenergy: IPO Proceeds Utilization Report for Q3 FY26
TruAlt Bioenergy Limited's IPO proceeds utilization report for Q3 FY26 shows ₹750 crore gross proceeds, with ₹519.63 crore utilized as of December 31, 2025. Net proceeds of ₹657.04 crore were allocated to capital expenditure, working capital, and general corporate purposes, including subsidiary investments.
Read the summary - Low impact
TruAlt Bioenergy: Audio Recording of Q3 FY26 Earnings Call Available
TruAlt Bioenergy released the audio recording of its Q3 FY26 earnings call. The call, held on February 9, 2026, discussed the unaudited standalone and consolidated financial results for the nine months ended December 31, 2025. The recording is available on the company's website.
Read the summary - High impact
TruAlt Bioenergy Wins Writ Petition; ₹1,075 Crore Ethanol Supply Case Allowed by High Court
TruAlt Bioenergy Limited's writ petition regarding a shortfall of 1,56,292 KL of ethanol, valued at ₹1,075 crore, was allowed by the Hon’ble High Court of Karnataka on February 4, 2026. The court directed OMCs to consider the company's representation, potentially enabling supply within an extended timeline and positively impacting financial performance.
Read the summary - High impact
TruAlt Bioenergy Q3 FY26: Revenue Up 70% to ₹730.86 Cr, Profit at ₹69.19 Cr
TruAlt Bioenergy reported Q3 FY26 total income of ₹730.86 crore, up 69.75% QoQ, and PAT of ₹69.19 crore. EBITDA increased 7.54% to ₹134.00 crore. The company commissioned grain integration capex and plans 24 new CBG units with Sumitomo and GAIL. A 100 million litres/annum SAF facility is planned, seeking ₹150 crore funding.
Read the summary - Low impact
TruAlt Bioenergy to hold Q3 FY26 earnings call on Feb 9, 2026
TruAlt Bioenergy Limited will host its Q3 FY26 earnings call on February 9, 2026, at 1:00 PM IST. The management will discuss financial results for the quarter and nine months ended December 31, 2025. A recording and transcript will be available on the company website.
Read the summary - Medium impact
TruAlt Bioenergy Ltd publishes financial results and announces significant business developments.
TruAlt Bioenergy Limited published Q3 FY26 results. The company is pursuing strategic acquisitions and divestitures, including a potential 70% stake acquisition in a biomass company. It is also selling its stake in another biomass project. Biomass supply is projected to grow significantly by December 2025. Land is being acquired for renewable energy projects.
Read the summary - High impact
TruAlt Bioenergy Q3 FY26 Investor Presentation: Ethanol Capacity Expansion & CBG Growth
TruAlt Bioenergy's Q3 FY26 investor presentation details ethanol plant commissioning and increased utilization. The CBG segment shows strong margins, with plans for 24 new units via JVs. SAF project progresses with Honeywell UOP, seeking ₹150 crore funding. Consolidated Q3 revenue grew 70.20% QoQ to ₹720.72 crore.
Read the summary - Low impact
TruAlt Bioenergy to Meet Analysts/Investors on Feb 9, 2026
TruAlt Bioenergy Limited will conduct a group meeting with analysts and investors on February 9, 2026, in Mumbai. Discussions will be limited to publicly available information.
Read the summary - Low impact
TruAlt Bioenergy Appoints Mr. Monu Kumar as Company Secretary & Compliance Officer
TruAlt Bioenergy Limited appointed Mr. Monu Kumar as Company Secretary and Compliance Officer on February 03, 2026. Mr. Kumar is a qualified Company Secretary and Law Graduate with over 11 years of experience in corporate governance and regulatory compliances.
Read the summary - Medium impact
TruAlt Bioenergy Appoints Monu Kumar as Company Secretary; Reports Q3 FY26 Results
TruAlt Bioenergy Limited reported its Q3 FY26 results and appointed Monu Kumar as Company Secretary. The company is developing a sustainable aviation fuel facility with Honeywell and a joint venture for compressed biogas plants with Sumitomo Corporation.
Read the summary - Medium impact
TruAlt Bioenergy Appoints Monu Kumar as Company Secretary; Reports Q3 FY26 Results
TruAlt Bioenergy Limited reported Q3 FY26 results with total income of ₹73,085.95 lakhs and profit before tax of ₹8,968.26 lakhs. The company appointed Mr. Monu Kumar as Company Secretary and Compliance Officer. Updates were provided on IPO utilization, a JV with Sumitomo Corporation, and an agreement with Honeywell for SAF production.
Read the summary - Low impact
TruAlt Bioenergy Appoints Mr. Monu Kumar as Interim Company Secretary and Compliance Officer
TruAlt Bioenergy Limited appointed Mr. Monu Kumar as Interim Company Secretary and Compliance Officer. Mr. Kumar is a qualified Company Secretary with over 11 years of experience in corporate governance and regulatory compliances. His appointment is effective immediately until a regular officer is appointed.
Read the summary - Low impact
TruAlt Bioenergy Appoints Mr. Monu Kumar as Interim Company Secretary and Compliance Officer
TruAlt Bioenergy Limited has appointed Mr. Monu Kumar as Interim Company Secretary and Compliance Officer, effective January 9, 2026. Mr. Kumar brings over 11 years of experience in corporate governance and regulatory compliance. His appointment is effective immediately until a regular officer is appointed.
Read the summary - Low impact
TruAlt Bioenergy: Certificate confirms non-applicability of Reg. 74(5) for Q3 FY26
TruAlt Bioenergy Limited received a certificate confirming non-applicability of SEBI Regulation 74(5) for the quarter ended December 31, 2025. This is because all shares are held in demat form, and no requests for rematerialization or dematerialization were received.
Read the summary - Low impact
TruAlt Bioenergy: Trading Window Closed From Jan 1, 2026, for Q3 FY26 Results
TruAlt Bioenergy Limited will close its trading window from January 1, 2026. The window will reopen 48 hours after the declaration of unaudited financial results for the quarter and nine months ending December 31, 2025. The board meeting date for results approval is yet to be intimated.
Read the summary - Medium impact
TruAlt Bioenergy Announces Earnings Conference Call Transcript and Business Updates
TruAlt Bioenergy releases Q2 results, impacted by plant shutdowns, but CBG business shows strong growth. Plans for SAF plant and expansion of retail fuel network are underway.
Read the summary - High impact
TruAlt Bioenergy to set up SAF plant in Andhra Pradesh with ₹2,250 Cr investment
TruAlt Bioenergy partners with APEDB to invest ₹2,250 crore in Andhra Pradesh for a Sustainable Aviation Fuel (SAF) plant, creating jobs and supporting India's clean energy goals.
Read the summary - Medium impact
TruAlt Bioenergy signs MoU with APEDB for SAF plant in Andhra Pradesh
TruAlt Bioenergy partners with APEDB to set up a ₹2,250 crore Sustainable Aviation Fuel plant in Andhra Pradesh, enhancing its presence in the green energy sector.
Read the summary - High impact
TruAlt Bioenergy re-submits Q1 FY26 results, announces strategic 51% acquisition of Trualt Gas Private Limited
TruAlt Bioenergy re-submitted Q1 FY26 results, approved financial results, and announced a strategic 51% acquisition of Trualt Gas Private Limited for ₹8.42 crore to expand into the CBG sector, expected to close by November 30, 2025.
Read the summary - Medium impact
TruAlt Bioenergy Publishes Q2FY26 Unaudited Financial Results, Board Approved on Nov 11, 2025
TruAlt Bioenergy published Q2FY26 unaudited consolidated financial results, approved by the Board on November 11, 2025. Net profit after tax was ₹1,453.28 crore.
Read the summary - Low impact
TruAlt Bioenergy Limited Announces Audio Recording of Earnings Conference Call
TruAlt Bioenergy Limited has released the audio recording of its earnings conference call held on November 13, 2025, to discuss the unaudited financial results for the quarter and half year ended September 30, 2025.
Read the summary - Low impact
TruAlt Bioenergy Limited Postpones Investor/Analyst Meet
TruAlt Bioenergy Limited has postponed its Investor/Analyst Meet originally scheduled for November 12, 2025, to November 13, 2025, due to unavoidable circumstances. The joining details will remain the same.
Read the summary - High impact
TruAlt Bioenergy Q2/H1 FY26: Planned Shutdowns for Dual-Feed Transition; CBG Grows 286%; ₹2,250 Cr SAF Plant MOU
TruAlt Bioenergy reported Q2/H1 FY26 results showing short-term dips due to planned dual-feed integration shutdowns. CBG segment saw 286% EBITDA growth. The company also announced a ₹2,250 crore MOU for an ethanol-to-SAF plant.
Read the summary - Medium impact
TruAlt Bioenergy Investor Presentation: Q2 & H1 FY26 Results
TruAlt Bioenergy's investor presentation for Q2 & H1 FY26 unveils strategic moves: SAF plant MoU with APEDB (₹2,250 crore investment), CBG plant construction (Sumitomo JV), and retail expansion. Dual-feed integration aims for year-round ethanol production.
Read the summary - Medium impact
TruAlt Bioenergy Enters Joint Venture with Sumitomo Corporation
TruAlt Bioenergy partners with Sumitomo Corp to develop CBG plants in India. TruAlt will hold 51% stake in JV, focusing on CBG production and distribution.
Read the summary - High impact
TruAlt Bioenergy reports Q2/H1 FY26 results, forms JV with Sumitomo for CBG, and eyes SAF plant with APEDB
TruAlt Bioenergy announced Q2/H1 FY26 results with losses, but highlighted a major CBG joint venture with Sumitomo, a planned ₹2,250 crore SAF plant with APEDB, and a GAIL partnership, alongside successful IPO listing.
Read the summary - High impact
TruAlt Bioenergy Approves Unaudited Financial Results & JV with Sumitomo Corp
TruAlt Bioenergy approves results for quarter ended Sept 30, 2025. Enters into JV with Sumitomo Corporation to scale CBG plants. IPO was oversubscribed and shares listed on NSE and BSE.
Read the summary - Low impact
TruAlt Bioenergy Limited Announces Q2&H1FY26 Earnings Call on 12 Nov 2025
TruAlt Bioenergy Limited will hold an earnings conference call on 12 November 2025 at 3:30 P.M. (IST) to discuss the financial results for Q2 & H1 FY26. Dial-in details are provided for various locations.
Read the summary - Medium impact
TruAlt Bioenergy to invest upto ₹20 Crore in Trualt Gas Private Limited
TruAlt Bioenergy to invest up to ₹20 Crore in subsidiary Trualt Gas Private Limited as part of a strategic JV initiative with Sumitomo Corporation. The aim is to strengthen TGPL’s operations before the joint venture.
Read the summary - Medium impact
Removal of Company Secretary and Compliance Officer
TruAlt Bioenergy Limited removed Mr. Deepak Kumar Gulati from the position of Company Secretary and Compliance Officer effective October 28, 2025, and is seeking a replacement.
Read the summary - Medium impact
TruAlt Bioenergy approves ₹180 Cr guarantee and share pledge for subsidiary's CBG plants
TruAlt Bioenergy approved a ₹180 crore corporate guarantee and pledged 51% shares in its subsidiary, Trualt Gas Private Limited, to secure a NABARD loan for three CBG plants.
Read the summary - Medium impact
TruAlt Bioenergy Board approves corporate guarantee & investment in subsidiary.
TruAlt Bioenergy's board approved a corporate guarantee and share pledge for its subsidiary's ₹180 crore NABARD loan, an additional ₹20 crore investment in the subsidiary, and the removal of the Company Secretary.
Read the summary - Medium impact
TruAlt Bioenergy approves corporate guarantee & investment in subsidiary
TruAlt Bioenergy approves corporate guarantee of 51% project cost for Trualt Gas Private Limited (TGPL) in favor of NABARD, pledging of shares & additional investment of upto ₹20 Crore in TGPL. Deepak Kumar Gulati removed as Company Secretary.
Read the summary - High impact
TruAlt Bioenergy Board Approves Q1 FY26 Results and Strategic 51% Acquisition of Trualt Gas Private Limited
TruAlt Bioenergy's board approved Q1 FY26 results and a strategic 51% acquisition of Trualt Gas Private Limited for ₹8.42 crore to expand in the Compressed Biogas sector by November 30, 2025.
Read the summary - High impact
TruAlt Bioenergy Reports Significant Profit Turnaround in Q1 FY26 Results
TruAlt Bioenergy reported strong Q1 FY26 unaudited results. Consolidated revenue grew to ₹30,389.17 lakh, and the company turned profitable with ₹472.52 lakh consolidated profit, a significant turnaround from last year's loss.
Read the summary - High impact
TruAlt Bioenergy Reports Strong Q1 FY26 Growth, Advances Dual-Feed Conversion and Biofuel Expansion
TruAlt Bioenergy reports strong Q1 FY26 results: 54% revenue growth, 122% PAT increase. Strategic dual-feed conversion, CBG, SAF, and biofuel retail expansion are underway, positioning for future growth.
Read the summary - High impact
TruAlt Bioenergy to acquire 51% stake in Trualt Gas Private Limited for ₹8.42 crore
TruAlt Bioenergy will acquire 51% of Trualt Gas Private Limited for ₹8.42 crore by November 30, 2025. This expands its presence in the compressed biogas sector, aligning with sustainable energy goals and facilitating a joint venture.
Read the summary - High impact
TruAlt Bioenergy Board Approves Q1 FY26 Results and Strategic 51% Acquisition of Trualt Gas Private Limited
TruAlt Bioenergy's Board approved Q1 FY26 results and a strategic acquisition of 51% stake in Trualt Gas Private Limited for ₹8.42 crore to expand into the CBG sector.
Read the summary - Low impact
TruAlt Bioenergy authorizes KMPs for material event disclosures under SEBI Regulation 30(5)
TruAlt Bioenergy Limited has authorized Key Managerial Personnel (KMP) to jointly determine materiality of events and make disclosures to stock exchanges under SEBI Regulation 30(5).
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio - Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio